Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 11;11(2):528. doi: 10.3390/biomedicines11020528

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

ATECNP (atezolizumab with carboplatin and nab-paclitaxel), ATECP (atezolizumab with carboplatin and paclitaxel), ATEBEVCP (atezolizumab with bevacizumab, carboplatin, and paclitaxel), and ATE (atezolizumab monotherapy). Forest plot of the adjusted association between antibiotic use and prognosis by study arm in the cohort randomised therapies with atezolizumab. Median time to progression-free survival (PFS) and overall survival (OS) are unadjusted. (A) Forest plot of association of antibiotics with PFS. (B) Forest plot of association of antibiotics with OS. (C) Forest plot of association of antibiotics with objective response rate (ORR).